Abeona Therapeutics (ABEO) Short Interest Ratio & Short Volume $6.26 +0.31 (+5.21%) Closing price 04:00 PM EasternExtended Trading$6.22 -0.04 (-0.72%) As of 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Abeona Therapeutics Short Interest DataAbeona Therapeutics (ABEO) has a short interest of 8.29 million shares, representing 18.30% of the float (the number of shares available for trading by the public). This marks a 28.33% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.6, indicating that it would take 4.6 days of the average trading volume of 703,871 shares to cover all short positions.Current Short Interest8,290,000 sharesPrevious Short Interest6,460,000 sharesChange Vs. Previous Month+28.33%Dollar Volume Sold Short$47.09 millionShort Interest Ratio4.6 Days to CoverLast Record DateJune 30, 2025Outstanding Shares51,157,000 sharesFloat Size45,310,000 sharesShort Percent of Float18.30%Today's Trading Volume1,034,277 sharesAverage Trading Volume703,871 sharesToday's Volume Vs. Average147% Short Selling Abeona Therapeutics? Sign up to receive the latest short interest report for Abeona Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartABEO Short Interest Over TimeABEO Days to Cover Over TimeABEO Percentage of Float Shorted Over Time Abeona Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20258,290,000 shares $47.09 million +28.3%18.3%4.6 $5.68 6/15/20256,460,000 shares $39.79 million +7.5%14.3%3.8 $6.16 5/31/20256,010,000 shares $36.90 million +2.0%13.3%3.7 $6.14 5/15/20255,890,000 shares $34.10 million +8.1%13.0%3.8 $5.79 4/30/20255,450,000 shares $35.75 million +97.5%12.6%4.3 $6.56 4/15/20252,760,000 shares $13.58 million +24.9%6.4%5 $4.92 3/31/20252,210,000 shares $10.52 million -7.5%5.2%5.2 $4.76 3/15/20252,390,000 shares $12.64 million -5.2%5.6%7.6 $5.29 2/28/20252,520,000 shares $13.20 million +2.0%6.6%9.3 $5.24 2/15/20252,470,000 shares $14.87 million -0.4%6.4%9.6 $6.02 Get the Latest News and Ratings for ABEO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Abeona Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20252,480,000 shares $13.74 million -6.8%6.5%9.1 $5.54 1/15/20252,660,000 shares $14.10 million +4.3%6.9%9.7 $5.30 12/31/20242,550,000 shares $14.20 million +0.8%6.5%10.1 $5.57 12/15/20242,530,000 shares $14.90 million -1.9%6.4%9.6 $5.89 11/30/20242,580,000 shares $16.49 million -1.9%6.6%9.6 $6.39 11/15/20242,630,000 shares $15.41 million -0.4%6.7%10.1 $5.86 10/31/20242,640,000 shares $16.92 million -4.7%6.7%10.6 $6.41 10/15/20242,770,000 shares $18.12 million +3.8%7.1%10.7 $6.54 9/30/20242,670,000 shares $16.87 million +1.5%6.8%8.9 $6.32 9/15/20242,630,000 shares $14.68 million -7.4%6.7%8.7 $5.58 8/31/20242,840,000 shares $16.19 million -6.3%7.3%8.2 $5.70 8/15/20243,030,000 shares $15.15 million +2.0%7.8%7.5 $5.00 7/31/20242,970,000 shares $14.55 million -3.6%7.7%6.5 $4.90 7/15/20243,080,000 shares $16.60 million -8.3%8.0%4 $5.39 6/30/20243,360,000 shares $14.25 million +26.8%8.5%4.6 $4.24 6/15/20242,650,000 shares $12.11 million +15.7%6.7%3.7 $4.57 5/31/20242,290,000 shares $10.03 million -24.2%5.8%3.2 $4.38 5/15/20243,020,000 shares $14.22 million -9.9%7.8%4.3 $4.71 4/30/20243,350,000 shares $13.87 million +62.6%12.9%5 $4.14 4/15/20242,060,000 shares $15.74 million +3.5%8.0%4.3 $7.64 3/31/20241,990,000 shares $14.43 million +17.1%7.7%6 $7.25 3/15/20241,700,000 shares $14.67 million +3.7%6.6%4.8 $8.63 2/29/20241,640,000 shares $11.32 million +5.1%7.0%5.4 $6.90 2/15/20241,560,000 shares $10.12 million +100.4%6.7%5.4 $6.49 1/31/2024778,500 shares $3.17 million +17.6%3.3%3.5 $4.07 1/15/2024662,100 shares $3.48 million +9.6%2.8%3.6 $5.25 12/31/2023603,900 shares $3.03 million +40.7%2.6%3.4 $5.01 12/15/2023429,200 shares $2.09 million -21.8%1.8%2.5 $4.87 11/30/2023549,000 shares $2.64 million -9.1%2.4%3.8 $4.80 11/15/2023603,700 shares $2.51 million -4.2%2.6%5.6 $4.15First time revealing what I do with my own money (Ad)My mom has made 3,400% returns - here’s her 3-Stock Secret' Joel Litman is an accountant. So is his mom, who’s made 3,400% stock market gains, beating 90% of pros. Her secret? Use just these 3 stocks her son recommended. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks. See if this unique approach is right for you.Click here to view… 10/31/2023630,400 shares $2.41 million +1.9%2.8%5.6 $3.82 10/15/2023618,500 shares $2.56 million 0.0%2.8%4.9 $4.14 9/30/2023618,700 shares $2.60 million +2.9%2.8%4.5 $4.21 9/15/2023601,400 shares $2.42 million +20.2%2.7%4.3 $4.03 8/31/2023500,500 shares $2.22 million +13.2%2.2%3 $4.43 8/15/2023442,000 shares $1.52 million -17.8%1.9%2.4 $3.45 7/31/2023538,000 shares $1.84 million -27.5%2.6%3.1 $3.42 7/15/2023742,500 shares $2.88 million +38.6%3.6%4.4 $3.88 6/30/2023535,900 shares $2.16 million +13.7%2.6%3.3 $4.03 6/15/2023471,400 shares $2.12 million +8.5%2.7%3 $4.49 5/31/2023434,500 shares $1.34 million +18.5%2.4%3 $3.09 5/15/2023366,600 shares $1.13 million -28.4%2.0%2.6 $3.08 4/30/2023512,300 shares $1.57 million -14.8%3.0%3.5 $3.07 4/15/2023601,000 shares $1.68 million -19.9%3.5%3.8 $2.79 3/31/2023750,500 shares $2.12 million +24.2%4.4%4.1 $2.82 3/15/2023604,400 shares $1.58 million +31.3%3.6%2.6 $2.62 2/28/2023460,500 shares $1.05 million +6.7%2.8%1.9 $2.29 2/15/2023431,600 shares $1.03 million -17.7%2.6%1.8 $2.38 1/31/2023524,300 shares $1.32 million -28.2%3.2%1.7 $2.52 1/15/2023730,200 shares $1.94 million -29.1%4.4%1.8 $2.65 12/30/20221,030,000 shares $3.17 million -4.6%6.2%2 $3.08 12/15/20221,080,000 shares $3.08 million +4.9%6.5%2.1 $2.85 11/30/20221,030,000 shares $3.87 million -3.7%6.2%2.1 $3.76 11/15/20221,070,000 shares $4.32 million +47.7%6.6%2.3 $4.04 10/31/2022724,600 shares $3.33 million +19.3%14.7%1.6 $4.59 10/15/2022607,300 shares $2.61 million +138.5%12.3%1.6 $4.30 9/30/2022254,600 shares $773.98 thousand +43.4%5.2%0.9 $3.04 9/15/2022177,500 shares $722.43 thousand -9.0%3.3%1 $4.07 8/31/2022195,100 shares $710.16 thousand -25.8%3.6%1.1 $3.64 8/15/2022263,000 shares $1.22 million +25.2%4.9%1.6 $4.65 7/31/2022210,100 shares $832.00 thousand -1.4%3.9%1.6 $3.96 7/15/2022213,100 shares $1.03 million +13.7%4.0%2 $4.85 6/30/2022187,500 shares $975.00 thousand -96.3%3.5%2 $5.20 6/15/20225,070,000 shares $819.82 thousand +17.4%N/A2.7 $0.16 5/31/20224,320,000 shares $725.76 thousand -1.8%N/A2.4 $0.17 5/15/20224,400,000 shares $712.36 thousand +8.9%N/A2.2 $0.16 4/30/20224,040,000 shares $834.26 thousand -13.3%N/A2.1 $0.21 4/15/20224,660,000 shares $1.27 million +18.3%N/A2.4 $0.27 3/31/20223,940,000 shares $1.24 million -2.5%N/A1.8 $0.32 3/15/20224,040,000 shares $1.04 million +9.5%N/A1.4 $0.26 2/28/20223,690,000 shares $952.02 thousand -21.0%N/A1 $0.26 2/15/20224,670,000 shares $1.25 million -7.9%N/A1.3 $0.27 1/31/20225,070,000 shares $1.29 million +242.6%N/A1.5 $0.26 1/15/20221,480,000 shares $404.04 thousand +13.9%N/A0.5 $0.27 12/31/20211,300,000 shares $438.10 thousand -3.0%N/A0.5 $0.34 12/15/20211,340,000 shares $698.14 thousand +47.8%1.5%0.6 $0.52 11/30/2021906,400 shares $624.51 thousand -57.0%1.0%1.2 $0.69 11/15/20212,110,000 shares $1.92 million -20.7%2.4%3 $0.91 10/29/20212,660,000 shares $2.16 million -8.3%3.1%4 $0.81 10/15/20212,900,000 shares $2.64 million +2.1%3.3%4.4 $0.91First time revealing what I do with my own money (Ad)My mom has made 3,400% returns - here’s her 3-Stock Secret' Joel Litman is an accountant. So is his mom, who’s made 3,400% stock market gains, beating 90% of pros. Her secret? Use just these 3 stocks her son recommended. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks. See if this unique approach is right for you.Click here to view… 9/30/20212,840,000 shares $3.18 million -12.4%3.3%3.4 $1.12 9/15/20213,240,000 shares $4.02 million -13.8%3.7%3.3 $1.24 8/31/20213,760,000 shares $4.96 million -18.3%4.3%3.4 $1.32 8/13/20214,600,000 shares $5.66 million -2.5%5.3%3.6 $1.23 7/30/20214,720,000 shares $5.76 million -1.1%5.4%3.3 $1.22 7/15/20214,770,000 shares $6.44 million +16.9%5.5%3.2 $1.35 6/30/20214,080,000 shares $6.36 million -34.4%4.8%2.6 $1.56 6/15/20216,220,000 shares $10.45 million -6.5%7.2%4 $1.68 5/28/20216,650,000 shares $10.97 million -14.6%7.7%4.1 $1.65 5/14/20217,790,000 shares $10.05 million +24.8%N/A3.3 $1.29 4/30/20216,240,000 shares $10.48 million +2.1%N/A1.7 $1.68 4/15/20216,110,000 shares $9.78 million +25.2%N/A1.6 $1.60 3/31/20214,880,000 shares $8.98 million -15.6%N/A1.2 $1.84 3/15/20215,780,000 shares $13.58 million +69.5%N/A1.4 $2.35 2/26/20213,410,000 shares $8.49 million +15.6%N/A0.8 $2.49 2/12/20212,950,000 shares $9.91 million +2.4%N/A0.8 $3.36 1/29/20212,880,000 shares $5.73 million +69.4%N/A1 $1.99 1/15/20211,700,000 shares $3.37 million -36.6%N/A0.7 $1.98 12/31/20202,680,000 shares $4.31 million +19.1%N/A1.3 $1.61 12/15/20202,250,000 shares $3.49 million +65.4%N/A0.9 $1.55 11/30/20201,360,000 shares $2.24 million -51.6%N/A0.6 $1.65 11/15/20202,810,000 shares $3.60 million -18.8%N/A1.3 $1.28 10/30/20203,460,000 shares $3.74 million +31.6%N/A1.8 $1.08 10/15/20202,630,000 shares $3.45 million +18.5%N/A1.6 $1.31 9/30/20202,220,000 shares $2.26 million -0.5%N/A1.4 $1.02 9/15/20202,230,000 shares $4.48 million No ChangeN/A2.5 $2.01 8/31/20202,230,000 shares $5.24 million +6.2%N/A2.6 $2.35 8/14/20202,100,000 shares $5.78 million -30.7%N/A2.4 $2.75 7/31/20203,030,000 shares $8.64 million +1.7%N/A3.2 $2.85 ABEO Short Interest - Frequently Asked Questions What is Abeona Therapeutics' current short interest? Short interest is the volume of Abeona Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 8,290,000 shares of ABEO short. 18.30% of Abeona Therapeutics' shares are currently sold short. Learn More on Abeona Therapeutics' current short interest. What is a good short interest ratio for Abeona Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABEO shares currently have a short interest ratio of 5.0. Learn More on Abeona Therapeutics's short interest ratio. What is a good short interest percentage for Abeona Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.30% of Abeona Therapeutics' floating shares are currently sold short. Is Abeona Therapeutics' short interest increasing or decreasing? Abeona Therapeutics saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 8,290,000 shares, an increase of 28.3% from the previous total of 6,460,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Abeona Therapeutics' float size? Abeona Therapeutics currently has issued a total of 51,157,000 shares. Some of Abeona Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Abeona Therapeutics currently has a public float of 45,310,000 shares. How does Abeona Therapeutics' short interest compare to its competitors? 18.30% of Abeona Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Abeona Therapeutics: Structure Therapeutics Inc. Sponsored ADR (13.40%), Harrow, Inc. (13.27%), Phibro Animal Health Corporation (4.68%), AbCellera Biologics Inc. (13.58%), Intellia Therapeutics, Inc. (30.02%), Amphastar Pharmaceuticals, Inc. (11.74%), WAVE Life Sciences Ltd. (73.25%), Aurinia Pharmaceuticals Inc (8.39%), Ardelyx, Inc. (12.17%), Enliven Therapeutics, Inc. (15.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Abeona Therapeutics stock? Short selling ABEO is an investing strategy that aims to generate trading profit from Abeona Therapeutics as its price is falling. ABEO shares are trading up $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Abeona Therapeutics? A short squeeze for Abeona Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABEO, which in turn drives the price of the stock up even further. How often is Abeona Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABEO, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Structure Therapeutics Short Interest Harrow Short Interest Phibro Animal Health Short Interest AbCellera Biologics Short Interest Intellia Therapeutics Short Interest Amphastar Pharmaceuticals Short Interest WAVE Life Sciences Short Interest Aurinia Pharmaceuticals Short Interest Ardelyx Short Interest Enliven Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ABEO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
